Belenger, Olivier

Founder and Managing Partner

Théo Risopoulos

Principal

Past deals in Belgium

Cascador Health

Seed Round in 2022
Contributes to better healthcare thanks to its platform allowing access to structured, validated and anonymised Real World Data.

ChromaCure

Venture Round in 2018
ChromaCure is engaged in the development of innovative cancer therapies, focusing on discovering first-in-class small molecule therapeutics to address unmet needs in oncology. The company is initiating a drug development program aimed at identifying new candidates that selectively and potently inhibit cancer targets. This initiative seeks to provide novel treatment options for multiple forms of cancer, either as standalone therapies or in combination with existing immunotherapy or chemotherapy approaches. Through its efforts, ChromaCure aims to enhance the therapeutic landscape for cancer patients, offering potential new solutions for various cancer types.

VIRTEO NV

Series A in 2018
VIRTEO NV, founded in 2013 and based in Mechelen, Belgium, operates a SaaS platform designed for the recovery of unpaid invoices. The platform addresses both internal dunning and external debt collection processes, catering to a diverse clientele that includes corporations, small and medium-sized enterprises, public institutions, court bailiffs, and lawyers. By facilitating direct collaboration between credit managers and external partners such as lawyers and recovery agencies, VIRTEO enhances efficiency, transparency, and compliance in debt collection. The company aims to reconcile the often negative perception of the debt collection industry with socially responsible practices, enabling creditors to recover debts while adhering to ethical standards. Through its platform, VIRTEO empowers customers to monitor, control, and enforce their corporate social responsibility policies, ultimately improving recovery outcomes and reducing costs.

PharmaFluidics

Venture Round in 2018
Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutions for any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring.

Acar'Up

Venture Round in 2017
Acar'Up develops and design a trap device designed to extract and kill the allergenic dust mites living in mattresses, chairs, carpets and other upholstered furniture.

X4C

Seed Round in 2016
X4C specializes in developing advanced molecular coatings for life science applications, focusing on in vitro diagnostics. The company utilizes innovative monolayer chemical coating technology to create robust organic monolayers that can be easily modified, allowing for enhanced functionality of various substrates. Their product offerings include nanoparticles and calixarenes, along with custom services tailored to meet specific industry needs. X4C's coatings are designed for a range of applications, including diagnostics, medical devices, electronics, and optics, ensuring that healthcare professionals can maintain the inherent properties of materials while enhancing their performance.

Domobios

Seed Round in 2016
Domobios specializes in developing innovative pest control solutions, primarily focusing on the eradication of domestic pests such as dust mites, lice, and bed bugs. The company's flagship product, Acar’up, is a user-friendly trap designed to effectively extract and eliminate allergenic dust mites from various surfaces, including mattresses, chairs, and carpets. In addition to Acar’up, Domobios offers a range of other pest management devices, including detectors that replicate the typical habitats of bedbugs, cockroach traps, and sprays for controlling dog mites. These products cater to diverse clients, including hotels, pest control companies, breeders, and homeowners, helping them enhance their living environments and improve overall quality of life through effective and eco-friendly solutions.

Domobios

Seed Round in 2015
Domobios specializes in developing innovative pest control solutions, primarily focusing on the eradication of domestic pests such as dust mites, lice, and bed bugs. The company's flagship product, Acar’up, is a user-friendly trap designed to effectively extract and eliminate allergenic dust mites from various surfaces, including mattresses, chairs, and carpets. In addition to Acar’up, Domobios offers a range of other pest management devices, including detectors that replicate the typical habitats of bedbugs, cockroach traps, and sprays for controlling dog mites. These products cater to diverse clients, including hotels, pest control companies, breeders, and homeowners, helping them enhance their living environments and improve overall quality of life through effective and eco-friendly solutions.

Ovizio

Venture Round in 2015
Ovizio specializes in digital holographic interferometric microscopy, creating advanced 4D microscopic imaging devices and associated software. The company targets scientists and biomanufacturers by offering automated cell culture monitoring and analysis systems that enhance the scaling of cell culture processes. Its technology is primarily aimed at the life sciences sector, specifically in bioprocessing and research and development. By utilizing digital holographic microscopy, Ovizio provides innovative solutions that support the growth and efficiency of scientific operations.

CluePoints

Series A in 2015
CluePoints® is a Risk-Based Monitoring and Central Statistical Monitoring solution that has been designed and perfected over the last 15 years. It employs unique statistical algorithms to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the ICH, FDA and EMA, CluePoints® is deployed to support traditional on-site monitoring, medical review and to drive a Risk-Based Monitoring strategy. The value of using CluePoints® lies in its powerful and timely ability to identify anomalous data and site errors allowing improvement in clinical data quality, optimization of on-site monitoring and a significant reduction in overall regulatory submission risk.

neoScores

Series A in 2015
neoScores is an innovative company based in Kontich, Belgium, that specializes in providing an online platform for purchasing and playing digital sheet music. Established in 2013 by three professional musicians—Bart Van der Roost, Bob Hamblok, and Jonas Coomans—the company aims to transform the way musicians access and utilize sheet music. The platform, known as Gustaf, is compatible across various operating systems and devices, enabling users to securely buy scores and share notes with fellow musicians from anywhere. With a focus on high-quality, flexible, and aesthetically pleasing digital scores, neoScores strives to enhance the musical experience for users, allowing them to engage with music seamlessly via smartphones, tablets, or computers.

PharmaFluidics

Venture Round in 2014
Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutions for any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.